Ellagic acid
Ellagic acid is a natural phenol antioxidant found in numerous fruits and vegetables. The antiproliferative and antioxidant properties of ellagic acid have prompted research into its potential health benefits, but it has been identified by the U.S. Food and Drug Administration as a fake cancer cure. Ellagic acid is the dilactone of hexahydroxydiphenic acid.
Names | |
---|---|
IUPAC name
2,3,7,8-Tetrahydroxy-chromeno[5,4,3-cde]chromene-5,10-dione | |
Other names
4,4′,5,5′,6,6′-Hexahydroxydiphenic acid 2,6,2′,6′-dilactone | |
Identifiers | |
3D model (JSmol) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.006.827 |
KEGG | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C14H6O8 | |
Molar mass | 302.197 g/mol |
Density | 1.67 g/cm3 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Name
The name comes from the French term acide ellagique, from the word galle spelled backwards[1] because it can be obtained from noix de galle (galls), and to distinguish it from acide gallique (gallic acid).
Metabolism
Biosynthesis
Plants produce ellagic acid from hydrolysis of tannins such as ellagitannin and geraniin.[2]
Biodegradation
Urolithins are gut flora human metabolites of dietary ellagic acid derivatives.[3][4] Ellagic acid has low bioavailability, with 90% remaining unabsorbed from the intestines until metabolized by microflora to the more bioavailable urolintins.[4]
History
Ellagic acid was first discovered by chemist Henri Braconnot in 1831.[5] Maximilian Nierenstein prepared this substance from algarobilla, dividivi, oak bark, pomegranate, myrabolams, and valonea in 1905.[5] He also suggested its formation from galloyl-glycine by Penicillium in 1915.[6] Julius Löwe was the first person to synthesize ellagic acid by heating gallic acid with arsenic acid or silver oxide.[5][7]
Natural occurrences
Ellagic acid is found in oak species such as the North American white oak (Quercus alba) and European red oak (Quercus robur).[8]
The macrophyte Myriophyllum spicatum produces ellagic acid.[9]
Ellagic acid can be found in the medicinal mushroom Phellinus linteus.[10]
In food
The highest levels of ellagic acid are found in raw chestnuts, walnuts, pecans, cranberries, raspberries, strawberries, and grapes, as well as distilled beverages.[11] It is also found in peaches[12] and pomegranates.[13]
Dietary source | Ellagic Acid[14] |
---|---|
Fruits (mg/100g fresh weight) | |
Blackberries | 150 |
Black raspberries | 90 |
Boysenberries | 70 |
Cloudberries | 315.1 |
Pomegranate | 269.9[15] |
Raspberries | 270 |
Rose hip | 109.6 |
Strawberries | 77.6 |
Strawberry jam | 24.5 |
Yellow raspberries | 1900 |
Nuts (mg/g) | |
Pecans | 33 |
Walnuts | 59 |
Beverages (mg/L) | |
Pomegranate juice | 811.1[15] |
Cognac | 31-55 |
Oak-aged red wine | 33 |
Whiskey | 1.2 |
Seeds (mg/g) | |
Black raspberries | 6.7 |
Red raspberries | 8.7 |
Boysenberries | 30 |
Mango | 1.2 |
Medicinal claims and research
An animal study demonstrated that ellagic acid and the microbial metabolite urolithin A from food sources increased beneficial bacteria, including Lactobacillales and Bifidobacterium.[4] Urolithin A derived from ellagic acid has been shown to reduce pro-inflammatory mediators such as interleukin 6 and tumor necrosis factor.[4]
Ellagic acid has been marketed as a dietary supplement with a range of claimed benefits against cancer, heart disease, and other medical problems. Ellagic acid has been identified by the U.S. Food and Drug Administration as a "fake cancer 'cure'".[16] A number of U.S.-based sellers of dietary supplements have received Warning Letters from the Food and Drug Administration for promoting ellagic acid with claims that violate the Federal Food, Drug, and Cosmetic Act.[17][18]
Urolithins, such as urolithin A, are microflora human metabolites of dietary ellagic acid derivatives that are under study as anti-cancer agents.[19] Claims that ellagic acid can treat or prevent cancer in humans have not been proven.[20]
See also
- List of ineffective cancer treatments
References
- Littré, Émile. "ellagique". Dictionnaire de la langue française.
- Seigler, David S. (31 December 1998). Plant Secondary Metabolism. Springer Science & Business Media. p. 208. ISBN 978-0-412-01981-4.
- Larrosa, M.; González Sarrías, A.; García Conesa, M. T.; Tomás Barberán, F. A.; Espín, J. C. (2006). "Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities". Journal of Agricultural and Food Chemistry. 54 (5): 1611–1620. doi:10.1021/jf0527403. PMID 16506809.
- Luca SV, Macovei I, Bujor A, Trifan A (2020). "Bioactivity of dietary polyphenols: The role of metabolites". Critical Reviews in Food Science and Nutrition. 60 (4): 626–659. doi:10.1080/10408398.2018.1546669. PMID 30614249.
- Grasser, Georg; Enna, F. G. A. (1922). Synthetic Tannins. p. 20. ISBN 9781406773019.
- Nierenstein, M. (1915). "The Formation of Ellagic Acid from Galloyl-Glycine by Penicillium". The Biochemical Journal. 9 (2): 240–244. doi:10.1042/bj0090240. PMC 1258574. PMID 16742368.
- Löwe, Julius (1868). "Über die Bildung von Ellagsäure aus Gallussäure" [On the synthesis of ellagic acid from gallic acid]. Zeitschrift für Chemie. 4: 603.
- Mämmelä, P.; Savolainen, H.; Lindroos, L.; Kangas, J.; Vartiainen, T. (2000). "Analysis of oak tannins by liquid chromatography-electrospray ionisation mass spectrometry". Journal of Chromatography A. 891 (1): 75–83. doi:10.1016/S0021-9673(00)00624-5. PMID 10999626.
- Nakai, S. (2000). "Myriophyllum spicatum-released allelopathic polyphenols inhibiting growth of blue-green algae Microcystis aeruginosa". Water Research. 34 (11): 3026–3032. doi:10.1016/S0043-1354(00)00039-7.
- Lee, Y.-S.; Kang, Y.-H.; Jung, J.-Y.; Lee, S.; Ohuchi, K.; Shin, K.-H.; Kang, I.-J.; Park, J.-H.; Shin, H.-K.; Lim, S.-S. (2008). "Protein glycation inhibitors from the fruiting body of Phellinus linteus". Biological and Pharmaceutical Bulletin. 31 (10): 1968–1972. doi:10.1248/bpb.31.1968. PMID 18827365.
- Vattem, D. A.; Shetty, K. (2005). "Biological Function of Ellagic Acid: A Review". Journal of Food Biochemistry. 29 (3): 234–266. doi:10.1111/j.1745-4514.2005.00031.x.
- Infante, R.; Contador, L.; Rubio, P.; Aros, D.; Peña Neira, Á. (2011). "Postharvest sensory and phenolic characterization of 'Elegant Lady' and 'Carson' peaches" (PDF). Chilean Journal of Agricultural Research. 71 (3): 445–451. doi:10.4067/S0718-58392011000300016.
- Usta, C.; Özdemir, S.; Schiariti, M.; Puddu, P. E. (November 2013). "The pharmacological use of ellagic acid-rich pomegranate fruit". International Journal of Food Sciences and Nutrition. 64 (7): 907–913. doi:10.3109/09637486.2013.798268. PMID 23700985.
- Landete, J.M. (2011). "Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health". Food Research International. 44 (5): 1150–1160. doi:10.1016/j.foodres.2011.04.027.
- García-Villalba, Rocío; Espín, Juan Carlos; Tomás-Barberán, Francisco A. (2016). "Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid". Journal of Chromatography A. 1428: 162–175. doi:10.1016/j.chroma.2015.08.044. PMID 26341594.
- "187 Fake Cancer 'Cures' Consumers Should Avoid". U.S. Food and Drug Administration. Archived from the original on May 2, 2017. Retrieved June 17, 2008.
- "Warning Letter sent to Millennium Health". Food and Drug Administration. May 21, 2008.
- "Warning Letter sent to Kenton Campbell at Prime Health Direct, Ltd" (PDF). Food and Drug Administration. July 2, 2007.
- Davis, C. D.; Milner, J. A. (2009). "Gastrointestinal microflora, food components and colon cancer prevention". Journal of Nutritional Biochemistry. 20 (10): 743–52. doi:10.1016/j.jnutbio.2009.06.001. PMC 2743755. PMID 19716282.
- "Ellagic acid". American Cancer Society. November 2008. Retrieved August 1, 2014.